PF-06372222

PF-06372222 is a drug which acts as a potent and selective allosteric antagonist of both the glucagon receptor and the glucagon-like peptide-1 receptor (GLP-1).

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

PF-06372222 is a drug which acts as a potent and selective allosteric antagonist of both the glucagon receptor and the glucagon-like peptide-1 receptor (GLP-1). It was originally developed as a potential treatment for diabetes but was unsuccessful, however it has subsequently been used as a pharmacological tool compound for the study of the GLP-1 receptor and led to the discovery of non-peptide GLP-1 agonists such as orforglipron.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1374092722 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001374092722 · captured 2026-09-09 · ledger · version history

Cite this page as: encyclopegia.org, “PF-06372222”, snapshot enwiki-001374092722. https://encyclopegia.org/a/pf-06372222

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.